Sort
130,381 grants matching “hiv”
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$2,787,572Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
PA04012, HIV PREVENTION PROJECTS
$2,787,288James M Vergeront · Wisconsin Department Of Health Services · U62 · FY2008 · PS
SUPPORT OF TRAINING OF HIV HEALTH CARE PROVIDERS IN THE REPUBLIC OF BOTSWANA UNDE
$2,786,962Tendani Gaolathe · Botswana-Harvard Aids Institute · U2G · FY2012 · PS
SUPPORT OF TRAINING OF HIV HEALTH CARE PROVIDERS IN THE REPUBLIC OF BOTSWANA UNDE
$2,786,962Tendani Gaolathe · Botswana-Harvard Aids Institute · U2G · FY2011 · PS
The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)
$2,786,855Charles W. Flexner · Johns Hopkins University · UM1 · FY2020 · AI
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
$2,786,708Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2022 · HL
Center for AIDS Research
$2,786,561Douglas D Richman · University Of California, San Diego · P30 · FY2010 · AI
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit
$2,786,202Jeffrey S Stringer · University Of Alabama At Birmingham · U01 · FY2009 · AI
Strategies for Eliciting bnAbs against Conserved HIV-1 Quaternary Epitopes
$2,785,302Abraham Pinter · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2010 · AI
East Africa International Epidemiologic Databases to Evaluate AIDS (IeDEA) Regional Consortium
$2,784,700Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2016 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$2,783,692Jeffrey Lennox · Emory University · UM1 · FY2018 · AI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)
$2,781,833Raphael Dolin · Beth Israel Deaconess Medical Center · UM1 · FY2015 · AI
Role of B Lymphocytes In HIV Infection And Pathogenesis
$2,781,737Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers
$2,781,188William C Olson · Progenics Pharmaceuticals, Inc. · P01 · FY2010 · AI
Optimizing the Immunogenicity of MVA-Based AIDS Vaccines
$2,780,254Mark B. Feinberg · Emory University · U19 · FY2006 · AI
INCREASING THE CAPACITY OF THE MINISTRY OF HEALTH TO EXPAND COORDINATED HIV PREVE
$2,779,432Rowland Swai · Tanzania Ministry Of Health/Social Wlfre · U2G · FY2009 · PS
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
$2,779,134Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2021 · HL
PS04-012, HIV PREVENTION PROJECTS
$2,776,267Lyell S Collins · Nevada State Dept Of Hlth/Human Svcs · U62 · FY2008 · PS
NEW TOOLS FOR EXPLORING THE DYNAMIC INTERACTOME(RMI)
$2,775,587Rockefeller University · U54 · FY2005 · RR
New Tools for Exploring the Dynamic Interactome(RMI)
$2,775,587Rockefeller University · U54 · FY2005 · RR
Synergies among inhibitory receptors in tolerance and disease
$2,775,439Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
$2,775,400Salim S Abdool Karim · University Of Kwazulu-Natal · U19 · FY2007 · AI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$2,772,513Myron E Essex · Harvard School Of Public Health · UM1 · FY2012 · AI
WOMENS INTERAGENCY HIV STUDY
$2,770,576Suny Downstate Medical Center · U01 · FY2002 · AI
IMPLEMENTATION & EXPANSION OF HIGH QUALITY HIV CARE, PREVENTION & TREATMENT
$2,770,000Paul Wekesa · Centre For Health Solutions · U2G · FY2011 · GH